All the latest packaging trends for life sciences, all at PACK EXPO East
Explore new packaging solutions for life sciences, all in one convenient location at PACK EXPO East, March 18 – 20 in Philadelphia.

'Biosimilar' legislation proposed in Colorado

Bill would allow pharmacists to substitute generic biotech drugs for brand-name biologicals if patient's doctor has access to the information.

Although they are not even on the market yet in the U.S., biosimilars are already taking center stage when it comes to politics.

Proposed legislation in Colorado would allow pharmacists there to substitute generic biotech drugs for brand-name biologicals if the patient's doctor has access to information about the change.

A similar bill was proposed in 2013, but, according to the Denver Business Journal, "died amid lobbying for and against the measure from big drug companies."

The big difference with the legislation then and now is that drug makers are backing the doctor notification portion of the wording. Previously, some companies argued that notifying the doctor was an unneeded step, and would prevent pharmacists from prescribint a biosimilar.

Test Your Supply Chain Smarts
Take Healthcare Packaging's supply chain quiz to prove your knowledge!
Read More
Test Your Supply Chain Smarts
Discover the right packaging solutions for life sciences in Philadelphia
Explore innovative packaging and supply chain solutions for the life sciences at the largest PACK EXPO East in history, March 18–20. Get ideas from 400+ top exhibitors and connect with colleagues and industry experts—all in one convenient location!
Read More
Discover the right packaging solutions for life sciences in Philadelphia